Birgit Luber
- Oncology top 2%
- HER2/EGFR in Cancer Research 12
- Colorectal Cancer Treatments and Studies 8
- Immunology and Allergy top 5%
- Cancer Research top 5%
- Hepatology top 5%
- Molecular Biology top 5%
- Wnt/β-catenin signaling in development and cancer 17
- Cancer-related gene regulation 14
- Kruppel-like factors research 8
-
- Gastric Cancer Management and Outcomes 13
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Hepatitis B Virus Studies 5
- Co-authors
- Heinz HöflerKarl‐Friedrich BeckerRaymonde BuschIngrid BeckerP. H. HofschneiderAlexander S. KekuléUlrich M. LauerErika Rosivatz
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Birgit Luber
57 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 114
- Oncology 1.3k
- Immunology and Allergy 171
- Cancer Research 418
- Hepatology 196
- Molecular Biology 1.4k
Countries citing papers authored by Birgit Luber
This map shows the geographic impact of Birgit Luber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Luber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Luber more than expected).
Fields of papers citing papers by Birgit Luber
This network shows the impact of papers produced by Birgit Luber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Luber. The network helps show where Birgit Luber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Birgit Luber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2022 | 7 | |
| 3 | 2020 | 7 | |
| 4 | 2017 | 14 | |
| 5 | 2015 | 1 | |
| 6 | 2012 | 26 | |
| 7 | 2011 | 321 | |
| 8 | 2010 | 61 | |
| 9 | 2009 | 48 | |
| 10 | 2009 | 42 | |
| 11 | 2008 | 62 | |
| 12 | 2008 | 67 | |
| 13 | 2007 | 31 | |
| 14 | 2004 | 31 | |
| 15 | 2004 | 70 | |
| 16 | 2004 | 11 | |
| 17 | 2002 | 16 | |
| 18 | 2000 | 31 | |
| 19 | 1999 | 72 | |
| 20 | 1993 | 36 |
About Birgit Luber
Birgit Luber is a scholar working on Oncology, Immunology and Allergy and Cell Biology, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (17 papers), Cancer-related gene regulation (14 papers), Gastric Cancer Management and Outcomes (13 papers), HER2/EGFR in Cancer Research (12 papers), Kruppel-like factors research (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology and Allergy (171 citations) and Cancer Research (418 citations). Birgit Luber has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Heinz Höfler, Karl‐Friedrich Becker, Raymonde Busch, Ingrid Becker, P. H. Hofschneider, Alexander S. Kekulé, Ulrich M. Lauer, Erika Rosivatz, Katja Specht and Peter Hutzler. Their work appears in journals such as Cancer Research, BMC Cancer, Experimental Cell Research, British Journal of Cancer and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.